Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology
- PMID: 24373310
- DOI: 10.1016/B978-0-12-800098-4.00001-5
Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology
Abstract
Dengue virus (DENV) is an emerging mosquito-borne human pathogen that affects millions of individuals each year by causing severe and potentially fatal syndromes. Despite intense research efforts, no approved vaccine or antiviral therapy is yet available. Overcoming this limitation requires detailed understanding of the intimate relationship between the virus and its host cell, providing the basis to devise optimal prophylactic and therapeutic treatment options. With the advent of novel high-throughput technologies including functional genomics, transcriptomics, proteomics, and lipidomics, new important insights into the DENV replication cycle and the interaction of this virus with its host cell have been obtained. In this chapter, we provide a comprehensive overview on the current status of the DENV research field, covering every step of the viral replication cycle with a particular focus on virus-host cell interaction. We will also review specific chemical inhibitors targeting cellular factors and processes of relevance for the DENV replication cycle and their possible exploitation for the development of next generation antivirals.
Keywords: DENV replication cycle; Dengue virus; High-throughput screen; Host dependency factors; Host restriction factors; Host-directed antivirals; Lipidomics; Proteomics; Transcriptomics; siRNA screen.
© 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Exploitation of cellular pathways by Dengue virus.Curr Opin Microbiol. 2011 Aug;14(4):470-5. doi: 10.1016/j.mib.2011.07.012. Epub 2011 Jul 27. Curr Opin Microbiol. 2011. PMID: 21798792 Review.
-
Dengue Virus Evolution under a Host-Targeted Antiviral.J Virol. 2015 May;89(10):5592-601. doi: 10.1128/JVI.00028-15. Epub 2015 Mar 11. J Virol. 2015. PMID: 25762732 Free PMC article.
-
Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses.Infect Genet Evol. 2011 Oct;11(7):1664-73. doi: 10.1016/j.meegid.2011.06.009. Epub 2011 Jun 21. Infect Genet Evol. 2011. PMID: 21722754
-
Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens.Nature. 2016 Jul 7;535(7610):159-63. doi: 10.1038/nature18631. Epub 2016 Jun 17. Nature. 2016. PMID: 27383987 Free PMC article.
-
Ten years of dengue drug discovery: progress and prospects.Antiviral Res. 2013 Nov;100(2):500-19. doi: 10.1016/j.antiviral.2013.09.013. Epub 2013 Sep 27. Antiviral Res. 2013. PMID: 24076358 Review.
Cited by
-
A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.J Virol. 2015 Jul;89(14):7170-86. doi: 10.1128/JVI.00867-15. Epub 2015 Apr 29. J Virol. 2015. PMID: 25926641 Free PMC article.
-
Renal Injury in DENV-4 Fatal Cases: Viremia, Immune Response and Cytokine Profile.Pathogens. 2019 Nov 7;8(4):223. doi: 10.3390/pathogens8040223. Pathogens. 2019. PMID: 31703246 Free PMC article.
-
Dengue and human health: A global scenario of its occurrence, diagnosis and therapeutics.Saudi J Biol Sci. 2021 Sep;28(9):5074-5080. doi: 10.1016/j.sjbs.2021.05.023. Epub 2021 May 20. Saudi J Biol Sci. 2021. PMID: 34466085 Free PMC article. Review.
-
The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking De Novo Formation of the Membranous Replication Compartment.J Virol. 2021 Oct 27;95(22):e0099621. doi: 10.1128/JVI.00996-21. Epub 2021 Sep 1. J Virol. 2021. PMID: 34468177 Free PMC article.
-
A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus Infection.J Virol. 2020 Mar 17;94(7):e01751-19. doi: 10.1128/JVI.01751-19. Print 2020 Mar 17. J Virol. 2020. PMID: 31915280 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
